Literature DB >> 16264271

Menin represses JunD transcriptional activity in protein kinase C theta-mediated Nur77 expression.

Hyungsoo Kim1, Ji Eun Lee, Bu Yeon Kim, Eun Jung Cho, Seong Tae Kim, Hong Duk Youn.   

Abstract

TCR signaling leading to thymocyte apoptosis is mediated through the expression of the Nur77 family of orphan nuclear receptors. It has been shown that the Nur77 promoter is activated by at least two signaling pathways, one mediated by calcium and the other by protein kinase C (PKC). MEF2D has been known to regulate Nur77 expression in a calcium- dependent manner. The mechanism by which calcium regulates MEF2D is through dissociation of calcium-sensitive MEF2 corepressors (Cabin1/HDACs, HDAC4/5) and the association with calcineurin-activated transcription factor NF-AT and the coactivator p300. However, little is known about how PKC activates the Nur77 promoter. Herein, we report that PKCtheta targets AP-1 like response element in the Nur77 promoter where JunD constitutively binds. PKCtheta triggers mitogen-activated protein kinase-inediated phosphorylation of JunD, and increases transcriptional activity of JunD, cooperatively with p300. Menin is identified as the transcriptional corepressor for JunD via recruitment of mSin3-istone deacetylases. In fact, Menin represses PKCtheta/p300-mediated transcriptional activity of JunD in T cell. Its dynamic regulation of histone modifiers with JunD is responsible for PKCq-synergistic effect on Nur77 expression in T cell.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16264271     DOI: 10.1038/emm.2005.57

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  10 in total

Review 1.  Genetics of pancreatic neuroendocrine tumors: implications for the clinic.

Authors:  Antonio Pea; Ralph H Hruban; Laura D Wood
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-09-28       Impact factor: 3.869

2.  Nur77 upregulates HIF-alpha by inhibiting pVHL-mediated degradation.

Authors:  Bu Yeon Kim; Hyungsoo Kim; Eun Jung Cho; Hong Duk Youn
Journal:  Exp Mol Med       Date:  2008-02-29       Impact factor: 8.718

3.  Genetic interactions between Drosophila melanogaster menin and Jun/Fos.

Authors:  Aniello Cerrato; Michael Parisi; Sonia Santa Anna; Fanis Missirlis; Siradanahalli Guru; Sunita Agarwal; David Sturgill; Thomas Talbot; Allen Spiegel; Francis Collins; Settara Chandrasekharappa; Stephen Marx; Brian Oliver
Journal:  Dev Biol       Date:  2006-06-10       Impact factor: 3.582

4.  MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia.

Authors:  Fiona C Brown; Eric Still; Richard P Koche; Christina Y Yim; Sumiko Takao; Paolo Cifani; Casie Reed; Shehana Gunasekera; Scott B Ficarro; Peter Romanienko; Willie Mark; Craig McCarthy; Elisa de Stanchina; Mithat Gonen; Venkatraman Seshan; Patrick Bhola; Conor O'Donnell; Barbara Spitzer; Crystal Stutzke; Vincent-Philippe Lavallée; Josée Hébert; Andrei V Krivtsov; Ari Melnick; Elisabeth M Paietta; Martin S Tallman; Anthony Letai; Guy Sauvageau; Gayle Pouliot; Ross Levine; Jarrod A Marto; Scott A Armstrong; Alex Kentsis
Journal:  Cancer Discov       Date:  2018-02-05       Impact factor: 39.397

5.  Protein kinase C regulates mitochondrial targeting of Nur77 and its family member Nor-1 in thymocytes undergoing apoptosis.

Authors:  Jennifer Thompson; Megan L Burger; Hannah Whang; Astar Winoto
Journal:  Eur J Immunol       Date:  2010-07       Impact factor: 5.532

6.  Nur77 suppresses pulmonary artery smooth muscle cell proliferation through inhibition of the STAT3/Pim-1/NFAT pathway.

Authors:  Yan Liu; Jian Zhang; Bing Yi; Ming Chen; Jia Qi; You Yin; Xiaotong Lu; Jean-Francois Jasmin; Jianxin Sun
Journal:  Am J Respir Cell Mol Biol       Date:  2014-02       Impact factor: 6.914

Review 7.  Multiple facets of junD gene expression are atypical among AP-1 family members.

Authors:  J M Hernandez; D H Floyd; K N Weilbaecher; P L Green; K Boris-Lawrie
Journal:  Oncogene       Date:  2008-04-21       Impact factor: 9.867

8.  Overexpression of myocyte enhancer factor 2 and histone hyperacetylation in hepatocellular carcinoma.

Authors:  Xueli Bai; Lihua Wu; Tingbo Liang; Zhiqiang Liu; Junjian Li; Donglin Li; Haiyang Xie; Shengyong Yin; Jun Yu; Qi Lin; Shusen Zheng
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-05       Impact factor: 4.553

9.  Menin mediates epigenetic regulation via histone H3 lysine 9 methylation.

Authors:  Y-J Yang; T-Y Song; J Park; J Lee; J Lim; H Jang; Y-N Kim; J-H Yang; Y Song; A Choi; H Y Lee; C H Jo; J W Han; S-T Kim; H-D Youn; E-J Cho
Journal:  Cell Death Dis       Date:  2013-04-11       Impact factor: 8.469

Review 10.  Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4).

Authors:  Rajesh V Thakker
Journal:  Mol Cell Endocrinol       Date:  2013-08-08       Impact factor: 4.102

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.